0.221
0.00 (1.33%)
| Penutupan Terdahulu | 0.218 |
| Buka | 0.216 |
| Jumlah Dagangan | 248,297 |
| Purata Dagangan (3B) | 692,075 |
| Modal Pasaran | 16,023,361 |
| Harga / Buku (P/B) | 3.11 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -0.270 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 276.80% |
| Nisbah Semasa (MRQ) | 0.290 |
| Aliran Tunai Operasi (OCF TTM) | -4.48 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -1.95 M |
| Pulangan Atas Aset (ROA TTM) | -151.41% |
| Pulangan Atas Ekuiti (ROE TTM) | -1,544.44% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Klotho Neurosciences, Inc. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 0.0 |
| Purata | -1.29 |
|
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 50.23% |
| % Dimiliki oleh Institusi | 2.60% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |